Luciano Pirone

Dr. Luciano Pirone

Biostructures and Bioimaging of C.N.R, V. Mezzocannone 16, 80134 Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Giovanni SmaldoneGiovanni Smaldone
Giovanni Smaldone
Luciano PironeLuciano Pirone
Luciano Pirone
NBNicole Balasco
Nicole Balasco
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
Emilia PedoneEmilia Pedone
Emilia Pedone
Luigi VitaglianoLuigi Vitagliano
Luigi Vitagliano
Cullin 3 (Cul3) recognition by BTB domains is a key process in protein ubiquitination. Among Cul3 binders, a great attention is currently devoted to KCTD proteins, which are implicated in fundamental biological processes. On the basis of the high similarity of BTB domains of these proteins, it has been suggested that the ability to bind Cul3 could be a general property among all KCTDs. In order to gain new insights into KCTD functionality, we here evaluated and/or quantified the binding of Cul3 to the BTB of KCTD proteins, which are known to be involved either in cullin-independent (KCTD12 and KCTD15) or in cullin-mediated (KCTD6 and KCTD11) activities. Our data indicate that KCTD6BTB and KCTD11BTB bind Cul3 with high affinity forming stable complexes with 4:4 stoichiometries. Conversely, KCTD12BTB and KCTD15BTB do not interact with Cul3, despite the high level of sequence identity with the BTB domains of cullin binding KCTDs. Intriguingly, comparative sequence analyses indicate that the capability of KCTD proteins to recognize Cul3 has been lost more than once in distinct events along the evolution. Present findings also provide interesting clues on the structural determinants of Cul3-KCTD recognition. Indeed, the characterization of a chimeric variant of KCTD11 demonstrates that the swapping of α2β3 loop between KCTD11BTB and KCTD12BTB is sufficient to abolish the ability of KCTD11BTB to bind Cul3. Finally, present findings, along with previous literature data, provide a virtually complete coverage of Cul3 binding ability of the members of the entire KCTD family.

10 January 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
FBF. Bellia
F. Bellia
VLValeria Lanza
Valeria Lanza
SGS. García-Viñuales
S. García-Viñuales
IAI. M. M. Ahmed
I. M. M. Ahmed
APA. Pietropaolo
A. Pietropaolo
Danilo MilardiDanilo Milardi
Danilo Milardi
Several lines of evidence point to a compromised proteostasis associated with a reduction of the Ubiquitin Proteasome System (UPS) activity in patients affected by Alzheimer's Disease (AD) and suggest that the amyloid β peptide (Aβ) is an important player in the game. Inspired also by many reports, underlining the presence of ubiquitin (Ub) in the amyloid plaques of AD brains, here we set out to test whether Ub may bind the Aβ peptide and have any effect on its clearance pathways. By using an integrated array of MALDI-TOF/UPLC-HRMS, fluorescence, NMR, SPR, Microscale Thermophoresis (MST) and molecular dynamics studies, we consistently demonstrated that Aβ40 binds Ub with a 1 : 1 stoichiometry and Kd in the high micromolar range. In particular, we show that the N-terminal domain of the Aβ peptide (through residues D1, E3 and R5) interacts with the C-terminal tail of Ub (involving residues K63 and E64), inducing the central region of Aβ (14HQKLVFFAEDVGSNK28) to adopt a mixed α-helix/β-turn structure. ELISA assays, carried out in neuroblastoma cell lysates, suggest that Aβ competitively binds Ub also in the presence of the entire pool of cytosolic Ub binding proteins. Ub-bound Aβ has a lower tendency to aggregate into amyloid-like fibrils and is more slowly degraded by the Insulin Degrading Enzyme (IDE). Finally, we observe that the water soluble fragment Aβ1–16 significantly inhibits Ub chain growth reactions. These results evidence how the non-covalent interaction between Aβ peptides and Ub may have relevant effects on the regulation of the upstream events of the UPS and pave the way to future in vivo studies addressing the role played by Aβ peptide in the malfunction of proteome maintenance occurring in AD.

1 April 2011 in Biochimie
Verified
Journal Article
Closed access
SCStefania Correale
Stefania Correale
Luciano PironeLuciano Pirone
Luciano Pirone
LMLucia Di Marcotullio
Lucia Di Marcotullio
ESEnrico De Smaele
Enrico De Smaele
AGAzzura Greco
Azzura Greco
Emilia PedoneEmilia Pedone
Emilia Pedone

12 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
Simona CamoraniSimona Camorani
Simona Camorani
LALisa Agnello
Lisa Agnello
Emilia PedoneEmilia Pedone
Emilia Pedone
Luciano PironeLuciano Pirone
Luciano Pirone
Laura CerchiaLaura Cerchia
Laura Cerchia
Photodynamic therapy (PDT) may be an excellent alternative in the treatment of breast cancer, mainly for the most aggressive type with limited targeted therapies such as triple-negative breast cancer (TNBC). We recently generated conjugated polymer nanoparticles (CPNs) as efficient photosensitizers for the photo-eradication of different cancer cells. With the aim of improving the selectivity of PDT with CPNs, the nanoparticle surface conjugation with unique 2’-Fluoropyrimidines-RNA-aptamers that act as effective recognition elements for functional surface signatures of TNBC cells was proposed and designed. A coupling reaction with carbodiimide was used to covalently bind NH2-modified aptamers with CPNs synthetized with two polystyrene-based polymer donors of COOH groups for the amide reaction. The selectivity of recognition for TNBC membrane receptors and PDT efficacy were assayed in TNBC cells and compared with non-TNBC cells by flow cytometry and cell viability assays. Furthermore, in vitro PDT efficacy was assayed in different TNBC cells with significant improvement results using CL4, sTN29 and sTN58 aptamers compared to unconjugated CPNs and SCR non-specific aptamer. In a chemoresistance TNBC cell model, sTN58 was the candidate for improving labelling and PDT efficacy with CPNs. We proposed sTN58, sTN29 and CL4 aptamers as valuable tools for selective TNBC targeting, cell internalization and therapeutic improvements for CPNs in PDT protocols.

14 February 2012 in Biochemistry
Verified
Journal Article
Closed access
FMFlavia Anna MERCURIO
Flavia Anna MERCURIO
daniela marascodaniela marasco
daniela marasco
Luciano PironeLuciano Pirone
Luciano Pirone
Emilia PedoneEmilia Pedone
Emilia Pedone
MPMaurizio Pellecchia
Maurizio Pellecchia
Marilisa LEONEMarilisa LEONE
Marilisa LEONE

1 July 2014 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
NBNicole Balasco
Nicole Balasco
Luciano PironeLuciano Pirone
Luciano Pirone
Giovanni SmaldoneGiovanni Smaldone
Giovanni Smaldone
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
luciana espositoluciana esposito
luciana esposito
Luigi VitaglianoLuigi Vitagliano
Luigi Vitagliano